UHLMANN PRICE SECURITIES’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
37,865
+2,263
+6% +$59.2K 0.03% 85
2026
Q1
$976K Buy
35,602
+21,201
+147% +$564K 0.07% 66
2025
Q4
$359K Sell
14,401
-2,412
-14% -$60.8K 0.21% 116
2025
Q3
$436K Sell
16,813
-1,470
-8% -$36.3K 0.27% 93
2025
Q2
$443K Sell
18,283
-1,556
-8% -$36.3K 0.32% 78
2025
Q1
$503K Sell
19,839
-1,413
-7% -$37K 0.37% 71
2024
Q4
$564K Sell
21,252
-540
-2% -$14.6K 0.43% 56
2024
Q3
$631K Buy
+21,792
New +$636K 0.5% 49

Other funds holding PFE

UHLMANN PRICE SECURITIES's PFE Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES increased its Pfizer (PFE) stake by 6.4% in Q2 2026, buying an estimated $59.2K and bringing the position to 37,865 shares worth $912K. The position accounts for 0.03% of the portfolio, ranked #85.

UHLMANN PRICE SECURITIES first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $976K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • UHLMANN PRICE SECURITIES held 37,865 shares of Pfizer worth $912K as of Q2 2026.
  • UHLMANN PRICE SECURITIES bought 2,263 Pfizer shares in Q2 2026, an estimated $59.2K.
  • Pfizer made up 0.03% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #85 holding.
  • UHLMANN PRICE SECURITIES first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • UHLMANN PRICE SECURITIES's Pfizer position peaked at $976K in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.